Summary
French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in therapeutic areas such as neurosciences, sciences, neurology, psychiatry, cancer, genetics, cancer, infectious diseases, metabolism, cell biology and immunology. It provides services in the areas of human diseases and research findings to the medical community, and to both national and international partners. INSERM operates under the joint authority of the French Ministry of Health and French Ministry of Research. The institute also conduct translational research and development services. It owns research units and research centers. INSERM is headquartered in Paris, France.
French National Institute of Health and Medical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
French National Institute of Health and Medical Research, Medical Devices Deals, 2011 to YTD 2017 11
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deal Details 15
Venture Financing 15
ILiAD Biotech Raises USD0.5 Million in Venture Financing 15
ILiAD Biotech Raises USD1 Million in Venture Financing 16
ILiAD Biotech Raises USD0.6 Million in Venture Financing 17
Partnerships 18
TxCell Enters into R&D Agreement with Inserm Transfert 18
Evotec Enters into Research Agreement with Inserm Transfert 19
Pierre Fabre Medicament Partners with Inserm Transfert 20
AstraZeneca Enters into Research Agreement with Inserm 21
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 22
Mifcare Enters into Agreement with Inserm 23
DBV Technologies Enters Into Research Agreement With Inserm For Viaskin 24
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 26
Covance Enters Into Co-Development Agreement With Inserm Transfert And Inserm Transfert Initiative 28
MedImmune Enters Into Co-Development Agreement With Inserm Transfert 29
Areva Enters into Research Agreement with French National Institute of Health and Medical Research 30
Licensing Agreements 31
TxCell Enters into Licensing Agreement with Inserm Transfert 31
TargEDys Enters into Licensing Agreement with Inserm Transfert, University of Rouen and Rouen University Hospital 32
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 33
Ultragenyx Pharma Enters into Licensing Agreement with Inserm Transfert and Institut du Cerveau et de la Moelle Epiniere 34
ElsaLys Biotech Enters into Licensing Agreement with Inserm Transfert 35
Brainvectis Enters into Licensing Agreement with INSERM 36
Inserm Transfert Enters into Licensing Agreement with HalioDx 37
IntegraGen Enters into Licensing Agreement with Inserm 38
Inotrem Enters into Licensing Agreement with University of Lorraine and INSERM 39
Acticor Biotech Enters into Licensing Agreement with Inserm Transfert 40
La Jolla Pharma Enters Into Licensing Agreement With Inserm To Develop Hepcidin Agonists 41
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 42
GlaxoSmithKline Enters Into Licensing Agreement With Inserm Transfert For Monoclonal Antibodies 43
Anagenesis Biotech Enters into Licensing Agreement with Inserm Transfert and AFM 44
GenSight Biologics Enters into Licensing Agreement with AFM, Genethon and Inserm Transfert 45
GenSight Biologics Enters into Licensing Agreement with Inserm Transfert 47
ViThera Pharma Enters into Licensing Agreement with French National Institute of Health and Medical Research and National Institute of Agricultural Research 49
French National Institute of Health and Medical Research - Key Competitors 50
French National Institute of Health and Medical Research - Key Employees 51
French National Institute of Health and Medical Research - Locations And Subsidiaries 52
Head Office 52
Other Locations & Subsidiaries 52
Affiliate 52
Recent Developments 53
Product News 53
07/19/2016: An Antibody-based Drug for Multiple Sclerosis 53
Apr 08, 2016: An effective drug for myoclonus-dystonia, a rare disease of the nervous system 54
Feb 29, 2016: Peptimimesis: New Biotech Startup Developing Next Generation Therapeutic Peptides In Immuno -Oncology, Oncology And Immune Diseases 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56
List of Tables
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Key Facts 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
French National Institute of Health and Medical Research, Deals By Therapy Area, 2011 to YTD 2017 10
French National Institute of Health and Medical Research, Medical Devices Deals, 2011 to YTD 2017 11
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
ILiAD Biotech Raises USD0.5 Million in Venture Financing 15
ILiAD Biotech Raises USD1 Million in Venture Financing 16
ILiAD Biotech Raises USD0.6 Million in Venture Financing 17
TxCell Enters into R&D Agreement with Inserm Transfert 18
Evotec Enters into Research Agreement with Inserm Transfert 19
Pierre Fabre Medicament Partners with Inserm Transfert 20
AstraZeneca Enters into Research Agreement with Inserm 21
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 22
Mifcare Enters into Agreement with Inserm 23
DBV Technologies Enters Into Research Agreement With Inserm For Viaskin 24
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 26
Covance Enters Into Co-Development Agreement With Inserm Transfert And Inserm Transfert Initiative 28
MedImmune Enters Into Co-Development Agreement With Inserm Transfert 29
Areva Enters into Research Agreement with French National Institute of Health and Medical Research 30
TxCell Enters into Licensing Agreement with Inserm Transfert 31
TargEDys Enters into Licensing Agreement with Inserm Transfert, University of Rouen and Rouen University Hospital 32
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 33
Ultragenyx Pharma Enters into Licensing Agreement with Inserm Transfert and Institut du Cerveau et de la Moelle Epiniere 34
ElsaLys Biotech Enters into Licensing Agreement with Inserm Transfert 35
Brainvectis Enters into Licensing Agreement with INSERM 36
Inserm Transfert Enters into Licensing Agreement with HalioDx 37
IntegraGen Enters into Licensing Agreement with Inserm 38
Inotrem Enters into Licensing Agreement with University of Lorraine and INSERM 39
Acticor Biotech Enters into Licensing Agreement with Inserm Transfert 40
La Jolla Pharma Enters Into Licensing Agreement With Inserm To Develop Hepcidin Agonists 41
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 42
GlaxoSmithKline Enters Into Licensing Agreement With Inserm Transfert For Monoclonal Antibodies 43
Anagenesis Biotech Enters into Licensing Agreement with Inserm Transfert and AFM 44
GenSight Biologics Enters into Licensing Agreement with AFM, Genethon and Inserm Transfert 45
GenSight Biologics Enters into Licensing Agreement with Inserm Transfert 47
ViThera Pharma Enters into Licensing Agreement with French National Institute of Health and Medical Research and National Institute of Agricultural Research 49
French National Institute of Health and Medical Research, Key Competitors 50
French National Institute of Health and Medical Research, Key Employees 51
French National Institute of Health and Medical Research, Subsidiaries 52
French National Institute of Health and Medical Research, Affiliate 52
List of Figures
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 8
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
French National Institute of Health and Medical Research, Medical Devices Deals, 2011 to YTD 2017 11
